Latest News

03.01.21

Glaucoma UK Launches New Services Booklet for People Living With Glaucoma

Source: Glaucoma UK

03.01.21

SalioGen Therapeutics Announces Closing of $20 Million Series A Financing to Advance Gene Therapies

Source: SalioGen Therapeutics

03.01.21

Bio-Tissue Receives FDA Clearance to Proceed with Clinical Study Using Investigational New Drug TTBT01

Source: Bio-Tissue

03.01.21

J&J’s COVID-19 Vaccine Wins FDA Authorization for Emergency Use

Source: FirstWord

03.01.21

Retinal Therapeutics Development Company Oxular Completes $37 Million (£27 million) Financing

Source: Oxular

03.01.21

Accure Therapeutics Enrolls First Patient in Phase 2 Clinical Trial on Acute Optic Neuritis

Source: Accure Therapeutics

03.01.21

Zubisoft Launches New Nomogram and Laser Treatment Planner for Zeiss SMILE

Source: Zubisoft

02.26.21

Envision Announces Call for Applications for Next Class of Research Fellows

Source: Envision

02.26.21

Study: Smartphones Could Help to Prevent Glaucoma Blindness

Source: University of Birmingham

02.26.21

Glaukos Announces Positive Phase 3 Trial Results for iLink Epi-On Investigational Therapy

Source: Glaukos

02.25.21

Remembering Ophthalmic Industry Executive George Marcellino

Source: Iridex

02.25.21

Moderna’s Variant-Specific COVID-19 Vaccine Candidate Ready for Clinical Testing

Source: FirstWord

02.24.21

New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Beyond Acute Disease into Chronic Phase

Source: Horizon Therapeutics

02.24.21

One-Dose J&J COVID-19 Vaccine Meets Criteria as Safe and Effective, FDA Report Finds

Source: USA Today

02.24.21

International Team Identifies 127 Glaucoma Genes in Largest Study of Its Kind

Source: Massachusetts Eye and Ear

02.24.21

NeurOptics Launches Virtual Pupillometry Education Platform

Source: NeurOptics

View more stories